ConvaTec Regulatory News (CTEC)

ConvaTec Group Plc ("the Company") - Total Voting Rights

Reading, United Kingdom (1 November 2017)

The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. On 31 October 2017 the Company's issued capital with voting rights consists of 1,951,850,599 ordinary shares of 10p each. The Company does not hold any shares in Treasury at the date of this disclosure.

The above figure (1,951,850,599) can be used by shareholders as the denominator for the calculations by which to determine if they are required to notify their interest in, or a change to, their interest in the Company under the UK Financial Conduct Authority's Disclosure and Transparency Rules.

Enquiries

Media

Bobby Leach, VP Group Corporate Affairs, ConvaTec +44 (0)7770 842 226

Alastair Elwen, Finsbury +44 (0)207 251 3801

Analysts and Investors

John Crosse, VP Investor Relations, ConvaTec +44 (0)7500 141 435

Kirsty Law, Director Investor Relations, ConvaTec +44 (0)7470 909 582

investorrelations@convatec.com

 ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.